NCT05086640

Brief Summary

For more than a decade, worldwide participation in ultra-marathons and ultra-trails (running races longer than the 42.195 km marathon) has been increasing. Although considered benign, blisters are a common problem, with serious consequences and limiting performance. Although blisters are a major factor limiting endurance performance, they are a reason for only 5.8% of ultra-trail runners to quit. While equipment is improving and participants are increasing and intensifying their training, there is no consensus on the prevention of blisters in ultra-trail running, even though it is the number one factor limiting sports performance. There are few prospective interventional studies on the prevention of blisters during outdoor activities. On many running forums, there is the hypothesis that lemon applied to the feet prevents the appearance of blisters. This hypothesis has never been scientifically studied. The investigators hypothesize that the local application of Lemon allows a reduction in the number of blisters on ultra-trail. The objective of this Blisters-stop 2 study is to evaluate the efficacy of local application of Lemon in preventing the appearance of blisters.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

September 3, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

October 21, 2021

Status Verified

May 1, 2021

Enrollment Period

1 month

First QC Date

September 3, 2021

Last Update Submit

October 7, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence or not of blisters at the end of the ultra-trail or at the time of abandonment.

    Blisters on each feet or non

    up to 1 week

Secondary Outcomes (5)

  • Feasibility of the protocole

    up to 1 week

  • Compliance

    up to 1 week

  • Tolerance

    up to 1 week

  • Main locations of residual blisters

    up to 1 week

  • Severity of residual blisters

    up to 1 week

Study Arms (2)

Lemon foot

EXPERIMENTAL

Application of Lemon in the Prevention of Blisters on one feet

Other: Lemon foot to prevent blister

Control foot without lemon

NO INTERVENTION

No application of Lemon or any other prevention cream in the Prevention of Blisters on one feet

Interventions

The investigators make the hypothesis that the local application of Lemon allows a reduction of the number of blisters on ultra-trail.

Lemon foot

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ultra-trail participants with validated registration
  • Major (≥ 18 years old)

You may not qualify if:

  • Presence of blisters or other skin lesions on the feet 28 days before the race
  • Amputation of one or two feet
  • Allergy to lemon
  • Psychiatric disorders making comprehension impossible
  • Lack of social security coverage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ifremmont

Chamonix, France

RECRUITING

Study Officials

  • Corentin Tanné

    Institut de Formation et de Recherche en Médecine de Montagne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2021

First Posted

October 21, 2021

Study Start

July 30, 2021

Primary Completion

August 31, 2021

Study Completion

December 31, 2021

Last Updated

October 21, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations